NCT07092332 Young Vulvodynia: Effect and Efficacy of Multimodal Treatment.
| NCT ID | NCT07092332 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Örebro County |
| Condition | Vulvodynia |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2025-06-10 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2025-06-10 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this SCED-study is to evaluate a multimodal treatment for vulvodynia in young women. The main questions it aims to answer are: Is multimodal treatment effective for provoked vulvodynia in young women? How is multimodal treatment experienced by young women with vulvodynia? Participants will respond to frequent questionnaires (two times a week) during a baseline period of 4,5 or 6 weeks, as well as during their treatment period ( a total of 25 weeks). In addition they will respond to pre-, post-treatment and 6 month follow-up questionnaires.
Eligibility Criteria
Inclusion Criteria: * Biological sex female * 15-23 years of age * Diagnosed with Provoked vulvodynia Exclusion Criteria: * Severe psychological issues that should be prioritized before vulvodynia treatment (e.g., substance abuse, psychosis) * Ongoing pregnancy * Childbirth within the last year * Post-traumatic stress disorder (PTSD) related to sexual trauma * Insufficient mastery of the Swedish language * No experience of vaginal sex, as vaginismus might be suspected, which requires different treatment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07092332 clinical trial?
This trial is open to female participants only, aged 15 Years or older, up to 23 Years, studying Vulvodynia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07092332 currently recruiting?
Yes, NCT07092332 is actively recruiting participants. Contact the research team at rebecca.lennartsson@regionorebrolan.se for enrollment information.
Where is the NCT07092332 trial being conducted?
This trial is being conducted at Örebro, Sweden.
Who is sponsoring the NCT07092332 clinical trial?
NCT07092332 is sponsored by Region Örebro County. The trial plans to enroll 15 participants.